Advice
following an abbreviated submission:
alteplase 2mg powder and solvent for solution for injection (Actilyse Cathflo®) is accepted for restricted use within NHS Scotland.
Indication under review: thrombolytic treatment of occluded central venous access devices including those used for haemodialysis.
SMC restriction: to use where alteplase is the product of choice for the treatment of occluded venous access devices.
This is a new formulation introduced for this extension to the alteplase marketing authorisation and the 2 ml vial is the only presentation licensed for this indication.
Download detailed advice39KB (PDF)
Medicine details
- Medicine name:
- alteplase (Actilyse Cathflo 2mg)
- SMC ID:
- 717/11
- Indication:
For thrombolytic treatment of occluded central venous access devices (CVAD).
- Pharmaceutical company
- Boehringer Ingelheim Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Abbreviated
- Status
- Restricted
- Date advice published
- 08 August 2011